Cytokinetics CYTK AOCI
AOCI at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's AOCI?
- Cytokinetics (CYTK) reported AOCI of -$1.61M in Q1 2026.
- How has Cytokinetics's AOCI changed year-over-year?
- Cytokinetics's AOCI decreased by 204.3% year-over-year, from $1.55M to -$1.61M.
- What is the long-term trend for Cytokinetics's AOCI?
- Over 5 years (2020 to 2025), Cytokinetics's AOCI has grown at a 33.4% compound annual growth rate (CAGR), from $149K to $630K.
- What does AOCI mean?
- A holding account for unrealized gains and losses not yet reflected in net income.
- How do you interpret AOCI?
- Significant fluctuations can indicate exposure to market volatility in investment portfolios or currency exchange risks.
- How does AOCI compare across companies?
- Common for companies with significant cash reserves invested in marketable securities.